EXEL(EXEL)
EXEL
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $2.55B | $2.86B | $3.19B | $3.40B | $3.03B |
| Low | $2.53B | $2.77B | $2.38B | $3.05B | $2.72B |
| High | $2.60B | $2.94B | $3.57B | $3.59B | $3.20B |
| EBITDA Avg | $1.28B | $1.43B | $1.62B | $1.83B | $1.60B |
| Low | $1.24B | $1.34B | $908M | $1.60B | $1.40B |
| High | $1.32B | $1.78B | $2.34B | $1.95B | $1.70B |
| EBIT Avg | $1.23B | $1.36B | $1.53B | $1.72B | $1.48B |
| Low | $1.19B | $1.27B | $817M | $1.49B | $1.28B |
| High | $1.27B | $1.71B | $2.25B | $1.84B | $1.58B |
| Net Income Avg | $978M | $1.08B | $1.22B | $1.36B | $1.17B |
| Low | $946M | $1.01B | $648M | $1.18B | $1.01B |
| High | $1.01B | $1.36B | $1.79B | $1.46B | $1.26B |
| EPS Avg | $3.51 | $4.08 | $4.65 | $4.83 | $4.16 |
| Low | $3.36 | $3.58 | $2.30 | $4.18 | $3.60 |
| High | $3.58 | $4.81 | $6.34 | $5.18 | $4.46 |
| Analysts (Rev / EPS) | 14 / 10 | 13 / 10 | 15 / 9 | 7 / 6 | 10 / 8 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $650M | $660M | $672M | $699M | $725M | $744M | $802M | $824M |
| Low | $639M | $642M | $647M | $673M | $698M | $717M | $773M | $794M |
| High | $665M | $687M | $699M | $727M | $754M | $774M | $835M | $857M |
| EBITDA Avg | $301M | $287M | $329M | $343M | $352M | $333M | $358M | $368M |
| Low | $274M | $260M | $314M | $328M | $336M | $318M | $342M | $351M |
| High | $314M | $303M | $345M | $361M | $370M | $349M | $376M | $386M |
| EBIT Avg | $291M | $277M | $317M | $330M | $337M | $317M | $341M | $350M |
| Low | $265M | $249M | $301M | $314M | $321M | $302M | $324M | $333M |
| High | $304M | $292M | $333M | $347M | $355M | $333M | $358M | $368M |
| Net Income Avg | $231M | $219M | $251M | $262M | $268M | $251M | $270M | $277M |
| Low | $210M | $198M | $239M | $249M | $255M | $239M | $257M | $264M |
| High | $241M | $231M | $264M | $275M | $282M | $264M | $284M | $292M |
| EPS Avg | $0.89 | $0.84 | $0.97 | $1.01 | $1.03 | $0.97 | $1.04 | $1.07 |
| Low | $0.81 | $0.76 | $0.92 | $0.96 | $0.98 | $0.92 | $0.99 | $1.02 |
| High | $0.93 | $0.89 | $1.02 | $1.06 | $1.08 | $1.02 | $1.09 | $1.12 |
| Analysts (Rev / EPS) | 11 / 8 | 11 / 8 | 9 / 3 | 5 / 5 | 5 / 3 | 6 / 6 | 9 / 4 | 4 / 6 |